Sibling-Support for Adolescent Girls (SSAGE)

Sponsor
Washington University School of Medicine (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06078124
Collaborator
Universidad de Los Andes (Other), Women's Refugee Commission (Other), National Institutes of Health (NIH) (NIH), Mercy Corps (Other)
180
2
12

Study Details

Study Description

Brief Summary

Forcibly displaced adolescents face increased risks for mental illness and distress, with adolescent girls disproportionately affected in part due to the heightened gender inequity that often accompanies forced displacement. Although the family unit has the potential to prevent mental illness and promote healthy development in adolescents, few family interventions have employed a gender transformative approach or included male siblings in an effort to maximize benefits for adolescent girls. Therefore, the investigators propose to assess an innovative whole-family and gender transformative intervention-Sibling Support for Adolescent Girls in Emergencies (SSAGE)-to prevent mental health disorders among adolescent girls in Colombia who were recently and forcibly displaced from Venezuela. The proposed R34 study will adapt the SSAGE curriculum through human-centered design with a range of stakeholders, including Venezuelan refugees, Colombian returnees and relevant civil society organizations. The proposed study will then employ a hybrid type 1 effectiveness-implementation pilot randomized control trial (RCT) to test the program's effectiveness and mechanistic pathways as well as to explore determinants of implementation in order to establish the feasibility, acceptability, and fidelity of SSAGE. To address these aims, the investigators will enroll 180 recently arrived, forcibly displaced adolescent girls in an RCT and examine the program's effectiveness on the prevention of mental illness (through reduction in anxiety, depression, interpersonal sensitivity, and somatization symptoms) one-month post-intervention. The investigators will use contextually adapted and piloted measures to collect additional data on the hypothesized mechanistic pathways, including family attachment, gender equitable family functioning, self-esteem, and coping strategies. The implementation evaluation will employ mixed methods to assess the program's feasibility, acceptability, fidelity and barriers and facilitators to successful implementation. Potential findings can support humanitarian program implementation, as well as inform policy to support adolescent girls' mental health and to prevent the myriad disorders that can arise as a result of exposure to displacement, conflict, and inequitable gender norms in their households and communities.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Sibling Support for Adolescent Girls in Emergencies
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
180 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
A hybrid type 1 effectiveness-implementation pilot randomized-controlled trial with one treatment arm and one control arm.A hybrid type 1 effectiveness-implementation pilot randomized-controlled trial with one treatment arm and one control arm.
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Sibling-Support for Adolescent Girls (SSAGE): A Whole-family, Gender Transformative Approach to Preventing Mental Illness Among Forcibly Displaced Adolescent Girls
Anticipated Study Start Date :
Sep 1, 2024
Anticipated Primary Completion Date :
Apr 30, 2025
Anticipated Study Completion Date :
Aug 31, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Sibling Support for Adolescent Girls in Emergencies (SSAGE)

Participants in this arm will participate in the Sibling Support for Adolescent Girls in Emergencies (SSAGE) intervention, along with three family members, for twelve weeks

Behavioral: Sibling Support for Adolescent Girls in Emergencies
The Sibling Support for Adolescent Girls in Emergencies (SSAGE) intervention is a gender-transformative, 12-week program utilizing a "whole family approach" wherein an adolescent girl, her male sibling, and a male and female caregiver participate in sessions that are age- and gender-specific and combined with family-wide discussions of session learnings. The sessions are interactive, engaging, and promote self-reflection and discussion on topics such as power, gender, interpersonal communication, and healthy relationships. Given the whole-family approach, SSAGE addresses intersections between spousal relationships, caregiver-child relationships, and relationships between siblings, as they pertain to supporting the mental health and psychosocial well-being of adolescent girls.
Other Names:
  • SSAGE
  • No Intervention: Control arm

    Care as usual

    Outcome Measures

    Primary Outcome Measures

    1. Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 Level 1 Cross-Cutting Symptom [Past two weeks]

      This measure includes 25 items and assesses the presence and severity of several psychiatric symptom domains including depression, anger, mania, anxiety, somatic symptoms, sleep disturbance, psychosis, obsessive thoughts and behaviors, suicidal thoughts and behaviors, substance use (e.g., alcohol, nicotine, prescription medication, and illicit substance use), inattention and irritability in children and adolescents. Nineteen of the items are rated on a 5-point scale (0=none/never; 1=slight/rare; 2=mild/several days; 3=moderate/more than half the days; and 4=severe/almost daily), where higher scores indicate higher frequency of occurrence or greater degree of severity. Questions on suicide ideation, suicide attempts, and substance use are rated on a 2-point scale of yes/no.

    2. Revised Children's Anxiety and Depression Scale (RCADS)-25 [Past two weeks]

      This scale assesses symptoms of depression and anxiety in children and adolescents using 25 items. Items are scored on a 4-point scale (0-never; 1-sometimes; 3-often; and 4-always). The total score is a sum of all item scores and can range from 0 to 100, with higher scores indicating more frequent/severe symptoms. Two subscales, representing depression and anxiety, can also be calculated. The Depression subscale can range from 0 to 40 and the Anxiety subscale can range from 0 to 60; for both subscales, higher scores indicate greater symptomology.

    Secondary Outcome Measures

    1. Family Attachment and Changeability Index (FACI-8) [Past two weeks]

      The FACI8 is a 16-item scale where each item is scored using a 5-point Likert scale of how frequently the event occurs (1-Never; 2-Sometimes; 3-Half of the time; 4-Most of the time; 5-Always). The FACI8 consists of two subscales: Attachment and Changeability. The eight items in the Attachment subscale are reverse coded and then summed to create a final score between 0 and 40, where higher scores reflect greater family attachment. The eight items in the Changeability suubscale are summed to create a final score between 0 to 40, where higher scores reflect greater flexibility of family relationships.

    2. Rosenberg Self-Esteem Scale [Past two weeks]

      The Rosenberg Self-Esteem Scale is a 10-item scale that measures positive and negative feelngs about the self to create a measure of overall self-worth. Items are scored using a 4-point Likert scale signaling level of agreement with each statement, from strongly agree to strongly disagree. Five items are reverse coded. The final score can take a value from 10 to 40, with higher scores indicating greater self-esteem.

    3. Kidcope [A stressor that occurred in the last two weeks]

      Kidcope is a 15-item checklist designed to measure cognitive and behavioural coping in children and adolescents. It measures the frequency and efficacy of ten coping strategies, including: problem-solving, distraction, social support, social withdrawal, cognitive restructuring, self-criticism, blaming others, emotional expression, wishful thinking and resignation. Items related to frequency are scored on a 4-point scale (0 = "Not at all" to 3 = "Almost all the time"), and items related to effectiveness are scored on a 5-point scale (0 = "Not at all" to 4 = "Very much"). Higher scores on the healthy and most effective coping behaviors are better.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    13 Years to 19 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Live with a male and female caregiver and an adolescent male sibling or relative

    • Immigrated to Colombia within the last year

    • Are available, along with their family members, to participate in the SSAGE intervention for three months

    • Are available to participate in survey questionnaires immediately before and one month after the intervention

    Exclusion Criteria:
    • None

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Washington University School of Medicine
    • Universidad de Los Andes
    • Women's Refugee Commission
    • National Institutes of Health (NIH)
    • Mercy Corps

    Investigators

    • Principal Investigator: Lindsay Stark, DrPH, Washington University School of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Washington University School of Medicine
    ClinicalTrials.gov Identifier:
    NCT06078124
    Other Study ID Numbers:
    • R34MH134078-01
    First Posted:
    Oct 11, 2023
    Last Update Posted:
    Oct 11, 2023
    Last Verified:
    Oct 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Washington University School of Medicine
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 11, 2023